Public signalCompany raiseAuto-indexed · Unverified
Strata Oncology, Inc. raised $6.1M
Strata Oncology, Inc.· ANN ARBOR, US· Other· Filed Nov 22, 2024
Strata Oncology, Inc. reported raising capital. Based in ANN ARBOR, MICHIGAN, US. First sale reported 2024-11-08. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$6.1M
Confidence90%
Raised
$6.1M
Investors
14
Jurisdiction
DELAWARE
On the record
- Location
- ANN ARBOR, US
- Sector
- Other
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $6.1M
- Target amount
- $10.0M
- Filing date
- Nov 22, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Other
- Number of investors
- 14
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $10.0M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Christopher O'Donnell
Director
Ann Arbor, US
Daniel Rhodes
Executive Officer
Ann Arbor, US
David Rubin
Director
Ann Arbor, US
James Pavlik
Director
Ann Arbor, US
Jan Garfinkle
Director
Ann Arbor, US
Jeffrey Williams
Executive Officer
Ann Arbor, US
Keith Flaherty
Director
Ann Arbor, US
Matthew Martin
Executive Officer
Ann Arbor, US
Sources & provenance
“Operating company sold 6,145,297 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Nov 22, 2024. Details beyond the filing have not been verified.
Tags
USCompanyOther$1M – $10MCompany Raise
Are you associated with Strata Oncology, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record